{"entity":{"type":"insider","cik":"0001890662","url":"/insider/0001890662","json_url":"/insider/0001890662.json","name":"Barry Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2024-02-08","last":"2025-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Barry Douglas","source":"filing","n_filings":2,"first_seen":"2024-02-08","last_seen":"2025-02-06"}],"transactions":[{"id":4525106,"accession":"0000950170-25-015704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-015704","line_url":"/filing/0000950170-25-015704#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001890662","owner_name":"Barry Douglas","owner_display_name":"Barry Douglas","owner_url":"/insider/0001890662","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2556.0,"shares_display":"2,556","price_per_share":3.1614,"price_display":"3.16","price_state":"stated","total_value":8080.5384,"total_display":"8,080.54","total_whole":"8,081","shares_owned_after":66014.0,"shares_owned_after_display":"66,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-06","scope":"insider"},{"id":4525102,"accession":"0000950170-25-015704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-015704","line_url":"/filing/0000950170-25-015704#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001890662","owner_name":"Barry Douglas","owner_display_name":"Barry Douglas","owner_url":"/insider/0001890662","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2774.0,"shares_display":"2,774","price_per_share":2.988,"price_display":"2.99","price_state":"stated","total_value":8288.712,"total_display":"8,288.71","total_whole":"8,289","shares_owned_after":68570.0,"shares_owned_after_display":"68,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":2512859,"accession":"0000950170-24-012997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-012997","line_url":"/filing/0000950170-24-012997#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001890662","owner_name":"Barry Douglas","owner_display_name":"Barry Douglas","owner_url":"/insider/0001890662","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1354.0,"shares_display":"1,354","price_per_share":12.6198,"price_display":"12.62","price_state":"stated","total_value":17087.2092,"total_display":"17,087.21","total_whole":"17,087","shares_owned_after":43981.0,"shares_owned_after_display":"43,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":2512854,"accession":"0000950170-24-012997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-012997","line_url":"/filing/0000950170-24-012997#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001890662","owner_name":"Barry Douglas","owner_display_name":"Barry Douglas","owner_url":"/insider/0001890662","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1422.0,"shares_display":"1,422","price_per_share":12.5626,"price_display":"12.56","price_state":"stated","total_value":17864.0172,"total_display":"17,864.02","total_whole":"17,864","shares_owned_after":45335.0,"shares_owned_after_display":"45,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819133","name":"Tango Therapeutics, Inc.","url":"/issuer/0001819133","role":"Officer (General Counsel)","n_filings":2,"first_seen":"2024-02-08","last_seen":"2025-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001890662","retrieved_at":"2026-08-25T19:15:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}